Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
暂无分享,去创建一个
N. Heerema | X. Wu | G. Reaman | F. Uckun | M. Sensel | L. Sun | A. Vassilev | C. Navara | Xian Wu | Lei Sun | L. Crotty | L. Sun | Lisa Crotty
[1] N. Heerema,et al. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. , 1998, Blood.
[2] M. Cleary,et al. What significance should we attribute to the detection of MLL fusion transcripts , 1998 .
[3] T. Kurosaki,et al. Electromagnetic Field-induced Stimulation of Bruton’s Tyrosine Kinase* , 1998, The Journal of Biological Chemistry.
[4] B. Morgan,et al. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors , 1998, Current Biology.
[5] F. Uckun,et al. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] J. Rowley. Backtracking leukemia to birth , 1998, Nature Medicine.
[7] I. Weissman,et al. Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] Matthias Merkenschlager,et al. Association of Transcriptionally Silent Genes with Ikaros Complexes at Centromeric Heterochromatin , 1997, Cell.
[9] M. Greaves,et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Rubnitz,et al. Molecular genetics of childhood cancer: implications for pathogenesis, diagnosis, and treatment. , 1997, Pediatrics.
[11] H. Sather,et al. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 1997, Blood.
[12] H. Sather,et al. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] B. Morgan,et al. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation , 1997, The EMBO journal.
[14] K. Georgopoulos,et al. Zinc finger‐mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. , 1996, The EMBO journal.
[15] T. Kurosaki,et al. BTK as a Mediator of Radiation-Induced Apoptosis in DT-40 Lymphoma B Cells , 1996, Science.
[16] M. Greaves. Infant leukaemia biology, aetiology and treatment. , 1996, Leukemia.
[17] K. Georgopoulos,et al. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma , 1995, Cell.
[18] A. Sharpe,et al. The ikaros gene is required for the development of all lymphoid lineages , 1994, Cell.
[19] S. Richards,et al. Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia. , 1994, Leukemia.
[20] N. Heerema,et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group. , 1994, Blood.
[21] J. Rowley,et al. Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23 , 1994 .
[22] M. Greaves,et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias , 1993, Nature.
[23] D. Moore,et al. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. , 1992, Science.
[24] B. Koller,et al. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. , 1989, Blood.
[25] N. Heerema,et al. Karyotypic and clinical findings in a consecutive series of children with acute lymphocytic leukemia. , 1985, Cancer genetics and cytogenetics.
[26] K. Georgopoulos,et al. The role of the Ikaros gene in lymphocyte development and homeostasis. , 1997, Annual review of immunology.
[27] M. Greaves,et al. Lineage promiscuity in hemopoietic differentiation and leukemia. , 1986, Blood.
[28] C. Bloomfield,et al. Translocation 4; 11 in acute lymphoblastic leukemia: clinical characteristics and prognostic significance , 1982 .
[29] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .